Navigation Links
University of North Texas Health Science Center Advances Forensic Research by Investing in Semiconductor DNA Sequencing Technology
Date:6/20/2012

CARLSBAD, Calif., June 20, 2012 /PRNewswire/ -- Life Technologies Corporation – (NASDAQ: LIFE) today announced a collaboration with the University of North Texas Health Science Center's  Institute of Applied Genetics utilizing the company's Ion Personal Genome Machine® (PGM™) system to further their research, development, and implementation of best technologies in forensic DNA analyses.

The Ion PGM™ Sequencer does not rely on light for sequencing, but rather translates chemical sequencing information directly into digital form by using semiconductor technology.  The result – sequencing that is simpler, faster, accurate, and more cost effective, than any other technology currently available.

"These are exciting times," said Dr. Bruce Budowle, Executive Director, Institute of Applied Genetics at the UNT Health Science Center.  "With the introduction of Life Technologies' Ion PGM™ Sequencer, application-oriented laboratories now have the sequencing power that has been the domain of large genome centers."  Added Budowle, "Massively parallel sequencing using an IonPGM™ Sequencer holds promise of advancing analyses to address forensic questions previously not believed feasible."

Both Drs. Budowle and Arthur Eisenberg, Professor and Chairman, Dept. of Forensic and Investigative Genetics at the UNT Health Science Center, will evaluate the use of the Ion PGM™ Sequencer for its utility and develop protocols on the system for a wide array of foren
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology news :

1. IOC recognizes University of Calgary Sports Injury Research Prevention Centre
2. Loss of biodiversity increasingly threatens human well-being: UBC, University of Michigan research
3. NIH supporting Arizona State University research to help in fight against kidney disease
4. University of Tennessee anthropologists find American heads are getting larger
5. Wells Fargo fosters environmental conservation through University of Miamis RJD program
6. University of Leicester study finds low agreeableness linked to a preference for aggressive dogs
7. University of Hawaii Cancer Center researchers create new anti-cancer drug
8. Richer parasite diversity leads to healthier frogs, says University of Colorado study
9. New museum-university partnership ushers in new era of environmental science education
10. Washington University receives $8 million to lead international childhood malnutrition effort
11. Virginia Tech and University of Tuscia lead team to unravel origin of devastating kiwifruit bacterium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/9/2015)... 9, 2015  Unchained Labs just can,t get ... of Avid Nano. Avid Nano designs, develops and ... Also today, Unchained Labs UNcaged ... to use protein sizing system. The pUNk is ... hydrodynamic size, size distribution, aggregation population and molecular ...
(Date:7/8/2015)... 8, 2015 Summary Pancreatic cancer is ... most fatal, with a mortality rate of 10.9 deaths ... pancreatic cancer patients has highlighted a significant need for ... being met by the current market. A highly ... with varying molecule types and mechanisms of action, which ...
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
Breaking Biology News(10 mins):Unchained Labs just can't get enough, acquires Avid Nano, rocks out the new pUNk! 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... A major challenge for cancer biologists is figuring out which ... cell are most important for driving the cancer,s spread. ... have now pinpointed a gene that appears to drive progression ... cancer accounting for about 15 percent of lung cancer cases. ...
... Richmond and Providence cities scattered across the eastern ... common, all have coal-fired power plants. A new study ... Indianapolis is among the first to investigate mercury deposits ... The study, which appears in the July 2011 ...
... & Melinda Gates Foundation has awarded Delft University of Technology ... Aim of this project is to develop new technology for ... lines, and at costs affordable to the poor in developing ... this grant today at the AfricaSan conference in Rwanda (www.africasan3.com) ...
Cached Biology News:New lung-cancer gene found 2Soil samples reveal urban mercury footprints 2Reinventing the toilet for safe and affordable sanitation 2
(Date:7/28/2015)... 28, 2015 Deerfield Management Company, L.P. today ... L.P., which will invest in groundbreaking advancements in science ... cancer, and orphan diseases. The venture capital fund will ... are developed and improve the way healthcare is delivered ... largest healthcare-focused venture funds in the sector, will donate ...
(Date:7/28/2015)... 2015 BioStructures, LLC, a privately held ... milestone of 4,000 implantations of Signafuse® Bioactive Bone ... early 2014 as a bone void filler indicated ... This is a distinguished status among recently cleared ... new synthetic products have received clearance with a ...
(Date:7/28/2015)... ZIONA, Israel , ... Ltd. (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing ... products, today announced that Shomrat Shurtz has been ... 20, 2015.      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ... over 25 years of experience in marketing, regulatory ...
(Date:7/27/2015)... , July 27, 2015 /PRNewswire/ - Quest PharmaTech ... company developing and commercializing products for the treatment of ... Quest announces that it has closed a $1,000,000 unit ... placement of 16,666,667 units of the Company at a ... of one common share and one common share purchase ...
Breaking Biology Technology:Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3Revolutionary Bone Graft Exceeds Expectations 2CollPlant Names Shomrat Shurtz Senior Director of Business Development 2Quest PharmaTech Closes $1,000,000 Private Placement 2
... ALISO VIEJO, Calif., May 5 ... Genomic Hybridization (CGH) using oligonucleotide arrays through a partnership ... abnormalities that are associated with over 270 genetic syndromes ... whole genome and mitochondrial array. The partnership with ...
... NEEDHAM, Mass., May 5 A new ... to improve both building systems performance and energy ... with much of the savings linked to low-cost modifications. ... Engineering, Inc. (EH&E), a leading Massachusetts-based environmental and ...
... HUBBARD, Ohio, May 5 NanoLogix, Inc. (Pink Sheets: ... technology at booth 749 during the 109th Annual ASM ... in Philadelphia May 17th - 21st. The ASM meeting ... NanoLogix will be Dr. Sergey Gazenko and CEO Bret ...
Cached Biology Technology:Ambry Genetics Announces the Addition of Array CGH Services Through Partnership With Baylor College of Medicine 2New Hospital Energy Performance Service Helps Hospitals Cut Energy Costs by 25% or More 2NanoLogix Inc. to Exhibit at The American Society for Microbiology (ASM) General Meeting in Philadelphia; Announces Two New Patents 2NanoLogix Inc. to Exhibit at The American Society for Microbiology (ASM) General Meeting in Philadelphia; Announces Two New Patents 3
Component in MasterPure™ Purification Kits...
Rabbit polyclonal to Quinolinic acid ( Abpromise for all tested applications). Antigen: Synthetic quinolinic acid conjugated to bovine serum albumin....
...
... Signets FAST RED Chromogen ... chromogen,tablets and substrate buffer. FAST ... of alkaline phosphatase to produce ... noise. The ...
Biology Products: